Department of Physical Chemistry, Chair and Department of Physical Pharmacy and Bioanalysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-093 Warsaw, Poland.
Int J Mol Sci. 2022 Sep 3;23(17):10099. doi: 10.3390/ijms231710099.
Propranolol, a non-cardioselective β blocker, is most commonly recognised for its application in the therapy of various cardiovascular conditions, such as hypertension, coronary artery disease, and tachyarrhythmias. However, due to its ability to cross the blood-brain barrier and affinity towards multiple macromolecules, not only adrenoreceptors, it has also found application in other fields. For example, it is one of the very few medications successfully applied in the treatment of stage fright. This review focuses on the application of propranolol in the treatment of various types of anxiety and stress, with particular reference to stage fright and post-traumatic stress disorder (PTSD). Both mechanisms of action as well as comparison with other therapies are presented. As those indications for propranolol are, in most countries, considered off-label, this review aims to gather information that can be useful while making a decision about the choice of propranolol as a drug in the treatment of those mental conditions.
普萘洛尔是一种非选择性β受体阻滞剂,最常用于治疗各种心血管疾病,如高血压、冠状动脉疾病和心动过速。然而,由于其能够穿过血脑屏障,并且对多种大分子(不仅仅是肾上腺素能受体)具有亲和力,因此它也在其他领域得到了应用。例如,它是极少数成功应用于治疗怯场的药物之一。本文综述了普萘洛尔在治疗各种焦虑和应激障碍中的应用,特别关注怯场和创伤后应激障碍(PTSD)。本文介绍了其作用机制,并与其他治疗方法进行了比较。由于在大多数国家,普萘洛尔的这些适应证都被认为是超适应证使用,因此,本文旨在收集信息,为在治疗这些精神疾病时选择普萘洛尔作为药物做出决策提供参考。